DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $660,194 | -9.1% | 2,661 | -12.0% | 1.22% | -11.3% |
| Q2 2023 | $726,000 | -46.6% | 3,025 | -43.9% | 1.38% | -56.0% |
| Q1 2023 | $1,360,007 | -5.4% | 5,396 | -0.4% | 3.13% | +9.1% |
| Q4 2022 | $1,437,514 | +2.4% | 5,416 | -0.4% | 2.87% | -7.3% |
| Q3 2022 | $1,404,000 | +1.3% | 5,436 | -0.5% | 3.09% | -5.2% |
| Q2 2022 | $1,386,000 | -13.9% | 5,466 | -0.4% | 3.26% | +177.8% |
| Q1 2022 | $1,609,000 | -11.0% | 5,486 | -0.2% | 1.18% | -5.3% |
| Q4 2021 | $1,808,000 | +8.1% | 5,496 | 0.0% | 1.24% | -3.7% |
| Q3 2021 | $1,673,000 | +4.4% | 5,496 | -7.9% | 1.29% | +3.4% |
| Q2 2021 | $1,602,000 | +3.0% | 5,970 | -13.7% | 1.25% | -6.5% |
| Q1 2021 | $1,556,000 | -4.7% | 6,914 | -6.0% | 1.33% | -16.9% |
| Q4 2020 | $1,633,000 | +27.9% | 7,353 | -16.8% | 1.60% | -7.6% |
| Q3 2019 | $1,277,000 | -7.3% | 8,839 | -8.3% | 1.74% | -3.4% |
| Q2 2019 | $1,378,000 | +14.2% | 9,639 | +5.5% | 1.80% | -28.6% |
| Q1 2019 | $1,207,000 | +44.4% | 9,139 | +12.7% | 2.52% | +18.9% |
| Q4 2018 | $836,000 | -6.1% | 8,109 | -1.0% | 2.12% | +90.7% |
| Q3 2018 | $890,000 | +10.1% | 8,191 | 0.0% | 1.11% | +2.4% |
| Q2 2018 | $808,000 | -3.0% | 8,191 | -3.8% | 1.08% | +15.2% |
| Q1 2018 | $833,000 | +3.2% | 8,511 | -0.4% | 0.94% | +20.9% |
| Q4 2017 | $807,000 | +18.5% | 8,548 | -1.5% | 0.78% | -9.6% |
| Q3 2016 | $681,000 | -12.2% | 8,682 | -4.7% | 0.86% | -41.7% |
| Q3 2015 | $776,000 | -13.5% | 9,106 | -13.1% | 1.48% | +41.9% |
| Q2 2015 | $897,000 | -3.2% | 10,473 | -4.0% | 1.04% | -2.4% |
| Q1 2015 | $927,000 | -1.7% | 10,911 | -0.8% | 1.07% | +16.8% |
| Q4 2014 | $943,000 | +0.5% | 10,996 | -11.0% | 0.91% | -43.6% |
| Q3 2014 | $938,000 | +0.1% | 12,354 | +3.8% | 1.62% | +61.2% |
| Q2 2014 | $937,000 | +8.7% | 11,900 | +3.5% | 1.01% | +16.2% |
| Q1 2014 | $862,000 | -4.5% | 11,500 | -1.7% | 0.87% | +60.7% |
| Q4 2013 | $903,000 | +10.3% | 11,700 | -1.0% | 0.54% | +3.5% |
| Q3 2013 | $819,000 | +9.1% | 11,822 | -0.4% | 0.52% | +7.9% |
| Q2 2013 | $751,000 | – | 11,874 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |